We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

Paragon 28 Inc (FNA) COM USD0.01

Sell:$6.40 Buy:$24.78 Change: $0.45 (2.91%)
Market closed |  Prices as at close on 20 May 2022 | Switch to live prices |
Change: $0.45 (2.91%)
Market closed |  Prices as at close on 20 May 2022 | Switch to live prices |
Change: $0.45 (2.91%)
Market closed |  Prices as at close on 20 May 2022 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Paragon 28, Inc. is a medical device company. The Company develops, distributes and markets medical devices in the foot and ankle segment of the orthopedic implant marketplace. The Company has developed a range of foot and ankle surgical systems and procedural techniques designed to address the primary conditions requiring treatment in the foot and ankle including fracture fixation, hallux valgus bunions, hammertoe, ankle, progressive collapsing foot deformity (PCFD) or flatfoot, Charcot foot, and orthobiologics. The products used in foot and ankle procedures include screws, wires and pins, plates, nails, fixators, staples, joint implants, soft tissue implants, orthobiologics and other implantation instruments and disposables. The Company has developed approximately 6,600 implant, 1,200 instrument, and 900 disposable and other stock keeping units (SKU’s). It has commercial footprint across United States and International.

Contact details

8310 South Valley Highway, Suite 3115
United States
+ ()

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
$1.16 billion
Shares in issue:
76.45 million
Health Care Equipment
United States
US dollar

Key personnel

  • Albert DaCosta
    President, Chief Executive Officer, Co-Founder
  • Frank Bono
    Co-Founder, Chief Technology Officer
  • Lee Rosenthal
    Co-Founder, Vice President - National Accounts
  • Steve Deitsch
    Principal Financial Officer
  • Brendan Shook
    Executive Vice President - Marketing and Medical Education
  • Matt Jarboe
    Chief Commercial Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.